Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
8.01
-0.04 (-0.50%)
At close: Jan 17, 2025, 4:00 PM
7.67
-0.34 (-4.22%)
After-hours: Jan 17, 2025, 5:16 PM EST
Ocular Therapeutix Employees
Ocular Therapeutix had 267 employees as of December 31, 2023. The number of employees decreased by 7 or -2.55% compared to the previous year.
Employees
267
Change (1Y)
-7
Growth (1Y)
-2.55%
Revenue / Employee
$230,120
Profits / Employee
-$652,951
Market Cap
1.26B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
OCUL News
- 3 days ago - Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 days ago - Ocular Therapeutix™ Shares SOL-R Enrollment Progress and Next Steps for AXPAXLI™ in NPDR - GlobeNewsWire
- 21 days ago - Ocular Is Now Thoroughly Derisked - Seeking Alpha
- 5 weeks ago - Ocular Therapeutix™ to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 7 weeks ago - Ocular Therapeutix™ Announces More Than 300 Subjects Randomized in SOL-1 - GlobeNewsWire
- 7 weeks ago - Ocular Therapeutix™ to Participate in December Investor and Scientific Conferences - GlobeNewsWire
- 2 months ago - Ocular Therapeutix, Inc. (OCUL) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Ocular Therapeutix™ to Present at the Jefferies London Healthcare Conference and Ophthalmology Innovation Summit XIV - GlobeNewsWire